Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study
β Scribed by K. Spargias; E. Adreanides; G. Giamouzis; S. Karagiannis; A. Gouziouta; A. Manginas; V. Voudris; G. Pavlides; D. V. Cokkinos
- Book ID
- 105921373
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 129 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The use of abciximab during percutaneous coronary angioplasty (PTCA) in patients with unstable angina (UA) prevents the postintervention enzyme surge and improves clinical outcomes, possibly by improving microcirculatory function. The aim of this quantitative myocardial blush grade (MBG) study was t
## Abstract **Objectives:** To investigate the safety of a novel percutaneous circulatory support device during highβrisk percutaneous coronary intervention (PCI). **Background:** The Reitan catheter pump (RCP) consists of a catheterβmounted pumpβhead with a foldable propeller and surrounding cage.